FOSTER

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Hong Kong, Croatia, Israel, Italy, Lithuania, Malta, Netherlands, Romania, Singapore, Tunisia, Turkey

Active ingredients

The drug FOSTER contains a combination of these active pharmaceutical ingredients (APIs):

1 Beclometasone
UNII 5B307S63B2 - BECLOMETHASONE DIPROPIONATE

Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity.

Read about Beclometasone
2 Eformoterol
UNII W34SHF8J2K - FORMOTEROL FUMARATE

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.

Read about Eformoterol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03AK08 Formoterol and beclometasone R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00568172, 04704614, 04704620, 04712654, 06139414, 06729452, 09313462, 09469098, 09469106, 09607761, 09607778, 09750300, 10130933, 10130956, 10733838, 10733850, 10918934, 10921669, 11003645, 11034870, 11305435, 11305441, 11305464, 11305470, 11606467, 11666989, 11685679, 11685745, 11692840, 11692857, 11731853, 11849968, 11849974, 12372592, 12535143, 12587884, 12893598, 12902311, 12902328, 13351391, 13351416, 13351422, 13351439, 13358252, 13358269, 13358275, 13358281, 13425712, 13425729, 14409750, 14409767, 15746797, 15746805, 16808106, 16808112, 16808129, 16808135, 16808141, 16808158, 16808170, 16808187, 16841150, 16841167
Country: EE Ravimiamet Identifier(s): 1314234, 1314256, 1369841, 1620087, 1620098, 1620100, 1653409, 1653410, 1653421, 1653432, 1653443, 1653454, 1788004, 1788015, 1788026, 1796991, 1797004, 1797015
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 68802, 76713, 80599, 80707
Country: HK Department of Health Drug Office Identifier(s): 61392
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7389, 9447
Country: IT Agenzia del Farmaco Identifier(s): 037789031, 037789106
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1005476, 1026899, 1034659, 1070740, 1072593, 1072594, 1073694, 1073699, 1079197, 1079198, 1079199, 1079200, 1087882, 1087883, 1087884, 1090056, 1090057, 1090058
Country: MT Medicines Authority Identifier(s): MA173/00702
Country: NL Z-Index G-Standaard, PRK Identifier(s): 102652, 104752, 129100, 129119, 84778
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W57995001, W57995002, W60547001, W60547002, W60547003, W60547004, W60547005, W60547006, W62574001, W62574002, W62574003, W62575001, W62575002, W62575003, W67117001, W67117002, W67117003, W67117004, W67117005, W67117006
Country: SG Health Sciences Authority Identifier(s): 13932P, 15332P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 7133071, 7133072, 7133073
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699822520173, 8699822520371, 8699822520432, 8699822550316, 8699822550385

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.